Theravance Biopharma (TBPH) Other Operating Expenses (2014 - 2026)
Theravance Biopharma (TBPH) posted quarterly Other Operating Expenses of $1.0 million for Q1 2026, up 102900.0% quarter-over-quarter from -$1000.0 in Q4 2025.
Theravance Biopharma (TBPH) Other Operating Expenses (2014 - 2026) Analysis & Trends
Theravance Biopharma (TBPH) has reported Other Operating Expenses for 11 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses changed N/A year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (down 77.24% YoY), while the FY2024 annual figure was $4.5 million, changed N/A from the prior year.
- Other Operating Expenses improved to $1.0 million in Q1 2026 per TBPH's latest filing, from -$1000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $3.0 million in Q2 2024 and bottomed at -$37.5 million in Q3 2022.
- Historically, Other Operating Expenses has averaged -$7.4 million across 4 years, with a median of $19000.0 in 2022.
- On a YoY basis, Other Operating Expenses climbed as much as 7.14% in 2022 and fell as far as 175.51% in 2022.
- Theravance Biopharma's Other Operating Expenses stood at $39000.0 in 2022, then soared by 3905.13% to $1.6 million in 2024, then slumped by 100.06% to -$1000.0 in 2025, then soared by 102900.0% to $1.0 million in 2026.
- Business Quant data shows TBPH's Other Operating Expenses at $1.0 million in Q1 2026, -$1000.0 in Q4 2025, and $1.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Theravance Biopharma | 880.59 Mn | 492.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.09 Mn |
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 2.95 Mn |
| Dec 31, 2022 | 39,000.00 |
| Sep 30, 2022 | -37.55 Mn |
| Jun 30, 2022 | -8.62 Mn |
| Mar 31, 2022 | -18.90 Mn |
| Dec 31, 2021 | 42,000.00 |
| Sep 30, 2021 | -13.63 Mn |
| Dec 31, 2020 | 130,000.00 |
| Dec 31, 2018 | 632,000.00 |
| Sep 30, 2018 | 705,000.00 |
| Jun 30, 2018 | -1.45 Mn |
| Mar 31, 2018 | 826,000.00 |
| Dec 31, 2017 | 3.12 Mn |
| Sep 30, 2017 | 985,000.00 |
| Jun 30, 2017 | 1.36 Mn |
| Mar 31, 2017 | 565,000.00 |